120 related articles for article (PubMed ID: 31669098)
1. Carcinogenic potential of fluorinated estrogens in mammary tumorigenesis.
Okamoto Y; Jinno H; Itoh S; Shibutani S
Toxicol Lett; 2020 Jan; 318():99-103. PubMed ID: 31669098
[TBL] [Abstract][Full Text] [Related]
2. Less Carcinogenic Chlorinated Estrogens Applicable to Hormone Replacement Therapy.
Okamoto Y; Jinno H; Itoh S; Shibutani S
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281275
[TBL] [Abstract][Full Text] [Related]
3. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone.
Turan VK; Sanchez RI; Li JJ; Li SA; Reuhl KR; Thomas PE; Conney AH; Gallo MA; Kauffman FC; Mesia-Vela S
J Endocrinol; 2004 Oct; 183(1):91-9. PubMed ID: 15525577
[TBL] [Abstract][Full Text] [Related]
4. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM; Singh B; Remotti F; Liu X; Bhat HK
Carcinogenesis; 2009 Jul; 30(7):1202-8. PubMed ID: 19406931
[TBL] [Abstract][Full Text] [Related]
5. Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat.
Harvell DM; Strecker TE; Xie B; Pennington KL; McComb RD; Shull JD
Carcinogenesis; 2002 Jan; 23(1):161-9. PubMed ID: 11756237
[TBL] [Abstract][Full Text] [Related]
6. Naturally-occurring estradiol-17beta-fatty acid esters, but not estradiol-17beta, preferentially induce mammary tumorigenesis in female rats: implications for an important role in human breast cancer.
Mills LH; Yu J; Xu XM; Lee AJ; Zhu BT
Toxicol Appl Pharmacol; 2008 Jun; 229(3):332-41. PubMed ID: 18394671
[TBL] [Abstract][Full Text] [Related]
7. Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.
Shull JD; Spady TJ; Snyder MC; Johansson SL; Pennington KL
Carcinogenesis; 1997 Aug; 18(8):1595-601. PubMed ID: 9276635
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis uncovered an association of serum phospholipid levels with estrogen-induced mammary tumors in female ACI/Seg rats.
Okamoto Y; Aoki A; Ueda K; Jinno H
Toxicol Lett; 2018 May; 288():65-70. PubMed ID: 29454887
[TBL] [Abstract][Full Text] [Related]
11. Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis.
Pemp D; Esch HL; Hauptstein R; Möller FJ; Zierau O; Bosland MC; Geppert LN; Kleider C; Schlereth K; Vollmer G; Lehmann L
Arch Toxicol; 2019 Jul; 93(7):1979-1992. PubMed ID: 31119341
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
13. Curcumin implants, not curcumin diet, inhibit estrogen-induced mammary carcinogenesis in ACI rats.
Bansal SS; Kausar H; Vadhanam MV; Ravoori S; Pan J; Rai SN; Gupta RC
Cancer Prev Res (Phila); 2014 Apr; 7(4):456-65. PubMed ID: 24501322
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices.
Aqil F; Jeyabalan J; Munagala R; Ravoori S; Vadhanam MV; Schultz DJ; Gupta RC
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212313
[TBL] [Abstract][Full Text] [Related]
15. Mammary tumor induction in ACI rats exposed to low levels of 17beta-estradiol.
Ravoori S; Vadhanam MV; Sahoo S; Srinivasan C; Gupta RC
Int J Oncol; 2007 Jul; 31(1):113-20. PubMed ID: 17549411
[TBL] [Abstract][Full Text] [Related]
16. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
Montano MM; Chaplin LJ; Deng H; Mesia-Vela S; Gaikwad N; Zahid M; Rogan E
Oncogene; 2007 May; 26(24):3587-90. PubMed ID: 17160017
[TBL] [Abstract][Full Text] [Related]
17. Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August-Copenhagen Irish rat.
Mesia-Vela S; Sanchez RI; Reuhl KR; Conney AH; Kauffman FC
J Pharmacol Exp Ther; 2006 May; 317(2):590-7. PubMed ID: 16421288
[TBL] [Abstract][Full Text] [Related]
18. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavone exposure through all life stages accelerates 17β-estradiol-induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats.
Möller FJ; Pemp D; Soukup ST; Wende K; Zhang X; Zierau O; Muders MH; Bosland MC; Kulling SE; Lehmann L; Vollmer G
Arch Toxicol; 2016 Aug; 90(8):1907-16. PubMed ID: 26861028
[TBL] [Abstract][Full Text] [Related]
20. Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.
Singh B; Bhat NK; Bhat HK
Carcinogenesis; 2012 Jan; 33(1):156-63. PubMed ID: 22072621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
